Lung cancer remains a major public health challenge globally and within Nigeria, accounting for significant morbidity and mortality rates among adults. Malignant tumors in the lung originate from the epithelial lining of the respiratory tract, disrupting normal gas exchange and invading surrounding intrathoracic structures. Nurses working in community health settings often encounter late-stage presentations due to delayed healthcare-seeking behaviors and overlapping symptoms with chronic respiratory infections like tuberculosis. Understanding the epidemiological burden helps nurses prioritize targeted health education campaigns and advocate for early diagnostic evaluations in primary healthcare facilities.
Lung cancer is broadly categorized into two major histological types that dictate treatment pathways and prognosis.
Early-stage lung cancer is frequently asymptomatic, which contributes to delayed diagnosis. As the tumor enlarges or metastasizes, clinical signs become apparent.
Accurate diagnosis and staging are essential to determine the extent of disease and guide therapeutic interventions. Diagnostic workups begin with a chest radiograph, followed by high-resolution computed tomography (CT) scans to visualize lesion characteristics and lymph node involvement. Confirmatory tissue diagnosis is obtained through bronchoscopy with biopsy, sputum cytology, or CT-guided needle aspiration. The TNM staging system—evaluating Tumor size, Node involvement, and Metastasis—is then applied to classify the cancer from localized disease to widespread metastasis.
Treatment strategies depend heavily on the cancer type, stage, and the patient's overall functional status. Surgical resection—ranging from wedge resection to pneumonectomy—offers the best chance for cure in localized non-small cell lung cancer. For patients with unresectable tumors or small cell lung cancer, systemic chemotherapy and external beam radiation therapy are the primary modalities. Targeted therapies and immunotherapy are also utilized when specific genetic mutations or protein markers are identified in the tumor tissue.
Nurses play a vital role in optimizing the comfort and respiratory status of patients undergoing treatment for lung cancer. Interventions focus on maintaining patent airways through controlled coughing exercises, adequate hydration to thin secretions, and prescribed bronchodilators. Pain management follows the WHO analgesic ladder, combining opioids and adjuvant medications for bone or chest wall pain. Nurses also monitor for treatment complications such as neutropenia, severe fatigue, and respiratory distress, providing continuous psychological support to the patient and their family.
Community health nursing efforts regarding lung cancer focus heavily on primary prevention and risk reduction. Nurses conduct educational outreach programs highlighting the dangers of tobacco smoking and promoting cessation support. In communities where biomass fuels are common, nurses advocate for improved kitchen ventilation and cleaner cooking energy alternatives. While large-scale screening programs using low-dose CT scans are resource-intensive, raising public awareness about persistent respiratory symptoms ensures prompt presentation to healthcare facilities for early evaluation.